Deep Track Capital, LP 13D and 13G filings for Edgewise Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-02-14 08:43 am Sale | 2023-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX | Deep Track Capital, LP | 2,537,176 4.000% | -837,218 (-24.81%) | Filing |
2022-09-23 4:11 pm Purchase | 2022-09-14 | 13G | Edgewise Therapeutics, Inc. EWTX | Deep Track Capital, LP | 3,374,394 5.340% | 3,374,394 (New Position) | Filing |